Related Experiment Video
Updated: Aug 26, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
De Novo Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models
Sara Romeo Atance1,2, Juan Viguera Diez1,2, Ola Engkvist1,2
1Molecular AI, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, 431 50Mölndal, Sweden.
Abstract:
Machine learning provides effective computational tools for exploring the chemical space via deep generative models. Here, we propose a new reinforcement learning scheme to fine-tune graph-based deep generative models for de novo molecular design tasks. We show how our computational framework can successfully guide a pretrained generative model toward the generation of molecules with a specific property profile, even when such molecules are not present in the training set and unlikely to be generated by the pretrained model. We explored the following tasks: generating molecules of decreasing/increasing size, increasing drug-likeness, and increasing bioactivity. Using the proposed approach, we achieve a model which generates diverse compounds with predicted DRD2 activity for 95% of sampled molecules, outperforming previously reported methods on this metric.
Related Concept Videos
Reinforcement
Positive reinforcement occurs when a behavior is followed by the presentation of a rewarding stimulus, increasing the frequency of that behavior. For example:
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Reinforcement Schedules
Once a behavior is learned,...
Observational Learning
Associative Learning
Classical conditioning, also known...
Drug Discovery: Overview

